Baricitinib (CAS 1187594-09-7): A Comprehensive Product Introduction
Baricitinib, with the CAS number 1187594-09-7, is a remarkable pharmaceutical compound that has gained significant attention in the medical and scientific communities. This article aims to provide a detailed introduction to Baricitinib, including its properties, uses, applications in various fields, and preparation methods.
Properties of Baricitinib
Baricitinib is a small – molecule inhibitor with a well – defined chemical structure. Chemically, it belongs to the class of Janus kinase (JAK) inhibitors. The molecular formula of Baricitinib is C₁₇H₁₈N₇O₂F, and it has a molecular weight of approximately 371.37 g/mol. It exists as a white to off – white powder, which is sparingly soluble in water but has better solubility in organic solvents such as dimethyl sulfoxide (DMSO) and methanol.
The compound has a specific melting point and a characteristic infrared (IR) and nuclear magnetic resonance (NMR) spectrum. These physical and chemical properties are crucial for its identification, purification, and quality control during the manufacturing process.
Uses of Baricitinib
Medical Use
One of the primary uses of Baricitinib is in the treatment of various autoimmune diseases. It acts by selectively inhibiting JAK1 and JAK2 kinases. JAK kinases play a key role in the signaling pathways of cytokines, which are important mediators of the immune response. By blocking these kinases, Baricitinib can reduce the over – activation of the immune system, which is characteristic of autoimmune diseases.
Rheumatoid Arthritis: Baricitinib has been approved for the treatment of moderate to severe rheumatoid arthritis in adults. In clinical trials, it has shown significant improvement in reducing joint pain, swelling, and stiffness. It can also slow down the progression of joint damage, thereby improving the quality of life for patients with rheumatoid arthritis. The recommended dosage for rheumatoid arthritis is usually 2 mg once daily.
Atopic Dermatitis: It has also been investigated and approved in some regions for the treatment of atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin condition characterized by itching, redness, and dryness. Baricitinib can help reduce the inflammation in the skin by modulating the immune response, leading to a reduction in symptoms and an improvement in the skin’s appearance.
COVID – 19: During the COVID – 19 pandemic, Baricitinib was studied for its potential use in treating severe cases of the disease. It was hypothesized that the inhibition of JAK kinases could reduce the cytokine storm, which is a life – threatening over – activation of the immune system seen in some COVID – 19 patients. Some clinical trials have shown that Baricitinib, when used in combination with other antiviral drugs, may improve the prognosis of severely ill COVID – 19 patients.
Research Use
Baricitinib is also widely used in scientific research. It serves as a valuable tool for studying the JAK – STAT signaling pathway. Researchers can use Baricitinib to investigate the role of JAK kinases in various biological processes, such as cell growth, differentiation, and immune regulation. By inhibiting JAK kinases with Baricitinib, scientists can gain insights into the functions of these kinases and develop new therapeutic strategies for related diseases.
Applications in Various Fields
Pharmaceutical Industry
In the pharmaceutical industry, Baricitinib is a key ingredient in the formulation of drugs for autoimmune diseases. Pharmaceutical companies invest heavily in the research, development, and production of Baricitinib – based medications. The production process involves strict quality control measures to ensure the safety and efficacy of the final products. These drugs are then distributed globally to meet the medical needs of patients suffering from rheumatoid arthritis, atopic dermatitis, and other related conditions.
Biotechnology Research
In the field of biotechnology research, Baricitinib is used in cell – based assays and animal models. It helps researchers understand the complex interactions between cells and the immune system. For example, in in vitro cell culture experiments, Baricitinib can be added to the culture medium to study the effects of JAK inhibition on cell proliferation and cytokine production. In animal models, it can be used to evaluate the potential therapeutic effects of JAK inhibitors in vivo, providing valuable data for the development of new drugs.
Clinical Trials
Baricitinib is actively involved in numerous clinical trials. These trials aim to explore its potential use in new indications, optimize the dosage regimens, and evaluate its long – term safety and efficacy. For example, ongoing clinical trials are investigating the use of Baricitinib in other autoimmune diseases such as lupus and psoriatic arthritis. The results of these trials will further expand the application scope of Baricitinib and provide more treatment options for patients.
Preparation Methods of Baricitinib
The synthesis of Baricitinib is a multi – step process that requires careful control of reaction conditions and purification steps. Here is a general overview of the preparation methods:
Starting Materials
The synthesis usually starts with commercially available starting materials. These materials are carefully selected based on their chemical properties and reactivity. For example, certain aromatic compounds and heterocyclic compounds are commonly used as the building blocks for the synthesis of Baricitinib.
Reaction Steps
Step 1: Formation of the Core Structure The first step involves the construction of the core heterocyclic structure of Baricitinib. This is usually achieved through a series of cyclization reactions. For example, a condensation reaction between appropriate amine and carbonyl compounds can form the basic ring structure. The reaction is carried out in the presence of a suitable catalyst and under specific reaction conditions, such as a certain temperature and pressure.
Step 2: Functional Group Introduction After the formation of the core structure, various functional groups are introduced to the molecule. This may involve reactions such as alkylation, acylation, and halogenation. For example, a fluorine atom can be introduced to the molecule through a fluorination reaction. These reactions are carefully designed to ensure the correct positioning and functionality of the introduced groups.
Step 3: Purification Once the synthesis is complete, the crude product is purified through various methods. These methods include column chromatography, recrystallization, and distillation. Column chromatography is often used to separate the desired product from impurities based on their different affinities to the stationary phase. Recrystallization can further purify the product by forming pure crystals under controlled conditions.
Send InquiryReferences
- Author, A. B. (Year). Title of the article. Journal Name, Volume(Issue), Page numbers.
- Author, C. D. (Year). Title of the book. Publisher.